Rights and permissions
About this article
Cite this article
Fluvoxamine study results ‘damaging’ and should be ‘ignored’. Pharmacoecon. Outcomes News 228, 5 (1999). https://doi.org/10.1007/BF03275073
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03275073